ConductScience.org, home

Paper3721771

Cycloserine as a urinary tract antiseptic.

Kaltenis P. Int Urol Nephrol, 1986. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Cycloserine as a urinary tract antiseptic. Papers, record 3721771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3721771

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cycloserine as a urinary tract antiseptic.
PubMed
Journal
Int Urol Nephrol
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.02
iCite
Revised in PubMed
2019-09-03
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaltenis PP

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CycloserineMajor topic
Urinary Tract InfectionsMajor topic
Adult
Child
Humans
Recurrence
Time Factors

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11091207[Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].Antibiotiki1975https://conductscience.org/library/papers/1091207PubMed
25272003The rythm of absorption and elimination of cycloserine as studied with the chromatographic technique.Scand J Respir Dis Suppl1970https://conductscience.org/library/papers/5272003PubMed
35683570Selection of antibiotics in acute pyelonephritis based on renal interstitial (lymph) concentrations.Br J Urol1968https://conductscience.org/library/papers/5683570PubMed
46610389In vitro activity of fludalanine combined with pentizidone compared with those of other agents.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6610389PubMed
57435512Adverse reactions to nitrofurantoin. Analysis of 921 reports.Am J Med1980https://conductscience.org/library/papers/7435512PubMed
914446135Reversal of cycloserine inhibition by D-alanine.Proc Soc Exp Biol Med1959https://conductscience.org/library/papers/14446135PubMed
106372464Prevention of urinary tract infections.Am J Med1984https://conductscience.org/library/papers/6372464PubMed
114896009Chronic bacteriuria due to Escherichia coli. I. Assessment of the value of combined short- and long-term treatment with cycloserine, nitrofurantoin, and sulphadimidine.J Infect Dis1969https://conductscience.org/library/papers/4896009PubMed
1213697941Treatment of urinary infections with cycloserine.Br Med J1960https://conductscience.org/library/papers/13697941PubMed
13779[Value of cycloserine (Tebemicin) in the treatment of acute attacks of chronic pyelonephritis].Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna1975https://conductscience.org/library/papers/779PubMed
14320482Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora.N Engl J Med1977https://conductscience.org/library/papers/320482PubMed
154845674Pharmacokinetics of cycloserine and terizidone. A comparative study.Chemotherapy1974https://conductscience.org/library/papers/4845674PubMed
164900788[Urovalidin in the treatment of chronic pyelonephritis. Clinical and bacteriological studies].Pol Arch Med Wewn1969https://conductscience.org/library/papers/4900788PubMed
1714401387Prolonged administration of cycloserine in recurrent urinary infections.J Urol1960https://conductscience.org/library/papers/14401387PubMed
2014045288ALANINE: CYCLOSERINE ANTAGONISM. II. SIGNIFICANCE OF PHENOMENON TO THERAPY WITH CYCLOSERINE.Arch Intern Med1963https://conductscience.org/library/papers/14045288PubMed
216992677Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial.Ann Intern Med1980https://conductscience.org/library/papers/6992677PubMed
2214425338Cycloserine in treatment of infection of urinary tract.Br Med J1959https://conductscience.org/library/papers/14425338PubMed
231137829Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.Can Med Assoc J1975https://conductscience.org/library/papers/1137829PubMed
244742957[Urovalidin Bracco in the therapy of urinary tract infections in children].Cesk Pediatr1973https://conductscience.org/library/papers/4742957PubMed
254107395Prevention of urinary-tract infection with low-dose nitrofurantoin.Lancet1971https://conductscience.org/library/papers/4107395PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
24474246Cycloserine as an alternative urinary tract infection therapy: susceptibilities of 500 urinary pathogens to standard and alternative therapy antimicrobials.Eur J Clin Microbiol Infect Dis2014https://conductscience.org/library/papers/24474246

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3721771

GET https://conductscience.org/api/papers/v1/3721771/references?page=2